Bacteriophage: Time to Re-Evaluate the Potential of Phage Therapy as a Promising Agent to Control Multidrug-Resistant Bacteria

Publish Year: 1391
نوع سند: مقاله ژورنالی
زبان: English
View: 297

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-15-2_002

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Nowadays the most difficult problem in treatment of bacterial infections is the appearance of resistant bacteria to the antimicrobial agents so that the attention is being drawn to other potential targets. In view of the positive findings of phage therapy, many advantages have been mentioned which utilizes phage therapy over chemotherapy and it seems to be a promising agent to replace the antibiotics. This review focuses on an understanding of phages for the treatment of bacterial infectious diseases as a new alternative treatment of infections caused by multiple antibiotic resistant bacteria. Therefore,utilizing bacteriophage may be accounted as an alternative therapy. It is appropriate time to re-evaluate the potential of phage therapy as an effective bactericidaland a promising agent to control multidrug-resistant bacteria.

Authors

Masoud Sabouri Ghannad

Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Avid Mohammadi

Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Tammelin A. Staphylococus aureus surgical wound infection; possibility of preventing ...
  • McNerney R, Traore H. Mycobacteriophage and their application to disease ...
  • Ackermann HW. Bacteriophage observations and evolution. Res Microbiol ۲۰۰۳; ۱۵۴:۲۴۵–۲۵۱ ...
  • ۴.Higgins SE, Higgins JP, Bielke LR, Hargis BM.Selection and application ...
  • Kutter E. Phage therapy: Bacteriophages as natural self-limiting antibiotics. AstraZeneca ...
  • Levin BR, Bull JJ. Phage Therapy revisited the population biology ...
  • Markoishvili K, Djavakhishvili N, Goderdzishvili M, Meipariani A, Chavchanidze Z, ...
  • Saunders ME. Bacteriophages in industrial fermentations. In:Webster R, Cranoff A.editors. ...
  • Soothill JS, Ayliffe GAJ. The efficacy of phages in the ...
  • Kokgohn TA, Schrader J, Waller JJ, Schrader HS. Effects of ...
  • Balow A and Duerden BI. Topley and Wilsons microbiology and ...
  • Pllitzer R.Cholera world health organization. Geneva. Switzerland. Available at: http;//www.evergreen.edu/user ...
  • Ross RP. Development of phage resisant starter strains infection control ...
  • Krueger AP, Northrop JH. The kinetics of the bacterium-bacteriophage reaction. ...
  • Payne RJH, Jansen VAA. Phage therapy, the peculiar kinetics of ...
  • Stencel Ch. Phages eyed as agents to protect against harmful ...
  • Thomas A, Lalitha MK., Jesudason MV, John S. Activity of ...
  • McKinstry M, Edgar R. Use of phages in therapy and ...
  • Little, JW. Lysogeny, prophage induction, and lysogenic conversion. In Waldor ...
  • Wagner PL, Waldor MK. Bacteriophage Control of Bacterial Virulence. Infect ...
  • Emami SA, Tayarani- NaJaran Z, Sabouri Ghannad M, Khajeh Karamadini ...
  • Khajeh Karamoddini M, Emami SA, Sabouri Ghannad M, Alizadeh Sani ...
  • Sabouri Ghannad M, Majzoobi MM, Ghavimi M, Mirzaei M. Needlestick ...
  • Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Gorski A. Bacterial viruses ...
  • Bradbury J. My enemy’s enemy is my friend. Lancet ۲۰۰۴; ...
  • Levin, B.R., Bull, J.J. Population and evolutionary dynamics of phage ...
  • Inal JM. Phag e therapy: a reappraisal of bacteriophages as ...
  • Stone R. Bacteriophage therapy: Stalin’s forgotten cure. Science ۲۰۰۲; ۲۹۸:۷۲۸–۷۳۱ ...
  • Sulakvelidze A, Alavidze Z, Morris JG. Bacteriophage therapy. Antimicrob Agents ...
  • Weber-Dabrowska B, Mulczyk M, Gorski A. Bacteriophage therapy of bacterial ...
  • Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ. ...
  • Garcia P, Garcia JL, Garcia E, Lopez R. Nucleotide sequence ...
  • Fischetti VA. Bacteriophage lytic enzymes: Novel anti-infectives. Trend Microbial ۲۰۰۵; ...
  • Low LY, Yang C, Perego M, Osterman A, Liddington RC. ...
  • Fischetti VA. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol ۲۰۰۵;۱۳: ...
  • Fishetti VA, Nelson D, Schuch R. Reinventing phage therapy: are ...
  • Leverentz B, Conway WS, Alavidze Z, Janisiewicz WJ, Fuchs Y, ...
  • Panthel K, Jechlinger W, Matis A, Rohde M, Rohde M, ...
  • Ebensen T, Paukner S, Link C, Kudela P, de Domenico ...
  • Young R, Wang IN, Roof WD. Phage will out: strategies ...
  • Remaut E, De Waele P, Marmeout A, Stanssens P, Fiers ...
  • Model P, Webster RE, Zinder ND. Characterization of Op۳, a ...
  • Arisaka F, Kanamaru S, Leiman P, Rossmann MG. The tail ...
  • Leiman PG, Kanamaru S, Mesyanzhinov VV, Arisaka F, Rossmann MG.Structure ...
  • Milller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, ...
  • Rossmann MG, Mesyanzhiniov VV, Arisaka F, Leiman PG.The bacteriophage T۴ ...
  • Sabouri Ghannad M, Zamani A. The full length hepatitis C ...
  • Embleton ML, Nair SP, Heywood W, Menon DC, Cookson BD,Wilson ...
  • ۴۹.Yacoby I, Shamis M, Bar H, Shabat D, Benhar I. ...
  • Larocca D, Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, ...
  • Hanlon GW. Bacteriophages: an appraisal of their role in the ...
  • Joerger RD. Alternatives to antibiotics: Bactericins, Antimicrobial peptides and Bacteriophages. ...
  • Alisky J, Iczkowski K, Rapoport A, Troitsky N. Bacteriophages how ...
  • Slopek S, Durlakowa I, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A. ...
  • ۵۵.Slopek S, Durlakowa I, Weber-Dabrowska B, Kucharewick-Krukowska A, Dabrowski M, ...
  • Slopek S, Durlakowa I, Weber-Dabrowska B, Kucharewick-Krukowska A, Dabrowski M, ...
  • Slopek S, Kucharewick-Krukowska A, Weber-Dabrowska B, Dabrowski M. Results of ...
  • ۵۸.Slopek S, Kucharewick-Krukowska A, Weber-Dabrowska B, Dabrowski M. Results of ...
  • Slopek S, Kucharewick-Krukowska A, Weber-Dabrowska B, Dabrowski M.Results of bacteriophage ...
  • Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewick-Krukowska A.Results of bacteriophage ...
  • Lood R., Collin M. Characterization and genome sequencing of two ...
  • Cheng CM, Wang HJ, Bau HJ, Kuo TT. The primary ...
  • ۶۳.Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Uijhara T, ...
  • Skurnik M, Strauch E. Phage therapy: facts and fiction. Int ...
  • Khajeh Karamoddini M, Fazli-Bazzaz BS, Emamipour F, Sabouri Ghannad M, ...
  • Bernhardt TG, Wang I, Struck DK, Young R. A protein ...
  • Bernhardt TG Wang, I, Struck DK, Young R..The lysis protein ...
  • Courchesne NM, Parisien A, Lan CQ. Production and application of ...
  • Petty NK, Evans TJ, Fineran PC, Salmond GPC. Biotechnological exploitation ...
  • Skurnik M, Strauch E. Phage therapy: facts and fiction. Int ...
  • نمایش کامل مراجع